REFRACTIVE LASER SURGERY STUDIES' INCLUSION CRITERIA SHOULD BE TIGHTENED, PANEL SAYS; NEGATIVE EFFECT ON PATIENT ENROLLMENT RAISED AS CONCERN BY INDUSTRY REP
This article was originally published in The Gray Sheet
Inclusion criteria for patients in clinical trials of refractive eye surgery lasers should be tightened, FDA's Ophthalmic Devices Panel concluded at its Oct. 21 meeting in Gaithersburg, Maryland.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.